9EW-32400-66730
5 vaccinations
12 coded responses
65 check-ins
11 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 930 / CA
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Moderna
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-19
- 2021-01-26
-
2021-02-02
Dose 2 — Moderna
- 2021-02-02
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Productive cough — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Cough with yellow phlegm. Once.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
-
2021-02-16
Survey response — day 14, dose 2MedDRA: Multiple sclerosis, Muscle spasticity, Pre-existing disease — Feeling: GoodFree text: Mild exacerbation of multiple sclerosis symptoms with Lhermittes sign in left leg and minimal left hip flexor spasticity for last 3-4 days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Survey response — day 21, dose 2MedDRA: Muscle spasticity, Pre-existing disease — Feeling: GoodFree text: Lhermittes sign and mild left hip flexor spasticity improving related to multiple Sclerosis. Mild symptoms do not interfere with daily activity.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-05-04
- 2021-08-03
-
2021-11-03
Dose 3 — Moderna
-
2021-11-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-05
Survey response — days 1–6 daily, dose 3MedDRA: Injection site erythema, Injection site pain — Feeling: Good · Site: Pain, Redness, SwellingFree text: Redness and tenderness in discrete regions adjacent to injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Survey response — days 1–6 daily, dose 3MedDRA: Injection site induration, Injection site rash, Nausea — Feeling: Good · Site: Pain, Redness, Swelling, Itching · NauseaFree text: Rash extends beyond injection site with some induration. Nausea was brief last evening.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-11-08
- 2021-11-09
- 2021-11-10
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2021-12-15
- 2022-02-02
- 2022-05-04
-
2022-08-05
Dose 4 — Moderna
- 2022-08-05
-
2022-08-06
Survey response — days 1–6 daily, dose 4MedDRA: Pyrexia, Tachycardia — Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tachycardia with feverMedDRA releases: 2024-11 · check-in free text available
- 2022-08-07
-
2022-08-08
Survey response — days 1–6 daily, dose 4MedDRA: Injection site erythema, Injection site pain, Injection site warmth — Feeling: GoodFree text: Redness, tenderness and warmth distal to injection site, mildMedDRA releases: 2024-11 · check-in free text available
- 2022-08-09
- 2022-08-10
-
2022-08-12
Survey response — day 7, dose 4MedDRA: Neck pain, Pre-existing disease — Feeling: GoodFree text: Twinges in left neck intermittently since 8/9/22 likely related to Lhermitte's from MS.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-19
- 2022-08-26
-
2022-09-02
Survey response — day 28, dose 4MedDRA: Tachycardia — Feeling: GoodFree text: Tachycardia since reduced dose of metoprolol last week.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-09
Survey response — day 35, dose 4MedDRA: Cough, Oropharyngeal pain — Feeling: GoodFree text: Sore throat and mild cough. No fever or nasal congestion.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-17
Survey response — day 42, dose 4MedDRA: Rhinorrhoea, Upper respiratory tract infection — Feeling: GoodFree text: Recovering from URI with residual clear rhinorrhea.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-04
-
2022-12-02
Dose 5 — Moderna
-
2022-12-03
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-12-04
- 2022-12-05
- 2022-12-06
- 2022-12-08
- 2022-12-09
- 2022-12-16
- 2022-12-23
- 2022-12-30
- 2023-01-06
- 2023-01-13
- 2023-03-03
-
2023-06-02
Survey response — 6 months, dose 5MedDRA: Asthma, Laryngitis, Nasal congestion, Oropharyngeal pain, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Moderna | |
| 2 | 2021-02-02 | Moderna | |
| 3 | 2021-11-03 | Moderna | No |
| 4 | 2022-08-05 | Moderna | No |
| 5 | 2022-12-02 | Moderna | No |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Cough with yellow phlegm. Once.
Release 4 — day 14, dose 2
Symptoms: Mild exacerbation of multiple sclerosis symptoms with Lhermittes sign in left leg and minimal left hip flexor spasticity for last 3-4 days.
Release 4 — day 21, dose 2
Symptoms: Lhermittes sign and mild left hip flexor spasticity improving related to multiple Sclerosis. Mild symptoms do not interfere with daily activity.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Redness and tenderness in discrete regions adjacent to injection site
Systemic reaction (other): Rash extends beyond injection site with some induration. Nausea was brief last evening.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Tachycardia with fever
Systemic reaction (other): Redness, tenderness and warmth distal to injection site, mild
Release 12 — day 7, dose 4
Systemic reaction (other): Twinges in left neck intermittently since 8/9/22 likely related to Lhermitte's from MS.
Release 12 — day 28, dose 4
Symptoms: Tachycardia since reduced dose of metoprolol last week.
Release 12 — day 35, dose 4
Symptoms: Sore throat and mild cough. No fever or nasal congestion.
Release 12 — day 42, dose 4
Symptoms: Recovering from URI with residual clear rhinorrhea.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Multiple sclerosis | ✓ | ✓ | ✓ |
| SD | Muscle spasticity | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site induration | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Injection site rash | · | · | ✓ |
| SRO | Injection site warmth | · | · | ✓ |
| SRO | Nausea | · | · | ✓ |
| SRO | Neck pain | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Productive cough | ✓ | ✓ | ✓ |
| SRO | Pyrexia | · | · | ✓ |
| SRO | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release